Alcohol and risk of breast cancer in postmenopausal women: An analysis of etiological heterogeneity by multiple tumor characteristics

American Journal of Epidemiology

Volumn 180, Issue 7, 2014, Pages 705-717

  Falk, Roni T ^a   Maas, Paige ^a   Schairer, Catherine ^a   Chatterjee, Nilanjan ^a   Mabie, Jerome E ^b   Cunningham, Christopher ^b   Buys, Saundra S ^c   Isaacs, Claudine ^d   Ziegler, Regina G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

alcohol; breast cancer; ductal carcinoma; estrogen receptor; lobular carcinoma; progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ALCOHOL; CANCER; COHORT ANALYSIS; HEALTH RISK; HETEROGENEITY; TUMOR; WOMENS HEALTH;

ADULT; AGED; ALCOHOL CONSUMPTION; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MIDDLE AGED; MULTIPLE CANCER; ORAL CONTRACEPTIVE USE; POSTMENOPAUSE; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; REPRODUCTIVE HISTORY; SMOKING; ADVERSE EFFECTS; BREAST NEOPLASMS; DRINKING BEHAVIOR; FOLLOW UP; METABOLISM; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

UNITED STATES;

AGED; ALCOHOL DRINKING; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 84930411940     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu189     Document Type: Conference Paper

References (28)

1. Hamajima N, Hirose K, Tajima K, et al. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002;87(11):1234-1245.
2. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;279(7):535-540.
3. Suzuki R, Orsini N, Mignone L, et al. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis of epidemiological studies. Int J Cancer. 2008;122(8):1832-1841.
4. Lew JQ, Freedman ND, Leitzmann MF, et al. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2009;170(3):308-317.
5. Li CI, Chlebowski RT, Freiberg M, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the Women's Health Initiative Observational Study. J Natl Cancer Inst. 2010;102(18):1442-1431.
6. Zhang SM, Lee IM, Manson JE, et al. Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epidemiol. 2007;165(6):667-676.
7. Suzuki R, Ye W, Rylander-Rudqvist T, et al. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst. 2005;97(21):1601-1608.
8. Chen WY, Rosner B, Hankinson SE, et al. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884-1890.
9. Bassett JK, Baglietto L, Hodge AM, et al. Dietary intake of B vitamins and methionine and breast cancer risk. Cancer Causes Control. 2013;24(8):1555-1563.
10. Horn-Ross PL, Canchola AJ, Bernstein L, et al. Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study. Cancer Epidemiol Biomarkers Prev. 2012;21(11):2006-2013.
11. Setiawan VW, Monroe KR, Wilkens LR, et al. Breast cancer risk factors defined by estrogen and progesterone receptor status: the Multiethnic Cohort Study. Am J Epidemiol. 2009; 169(10):1251-1259.
12. Park SY, Kolonel LN, Lim U, et al. Alcohol consumption and breast cancer risk among women from five ethnic groups with light to moderate intakes: the Multiethnic Cohort Study. Int J Cancer. 2014;134(6):1504-1510.
13. Sellers TA, Vierkant RA, Cerhan JR, et al. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002;11(10 Pt 1): 1104-1107.
14. Hammond MEH, Hayes DF, Dowsett M, et al. ASCO-CAP guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784-2795.
15. Kotsopoulos J, Chen WY, Gates MA, et al. Risk factors for ductal and lobular breast cancer: results from the Nurses' Health Study. Breast Cancer Res. 2010;12(6):R106.
16. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9): 1046-1052.
17. Rosner B, Glynn RJ, Tamimi RM, et al. Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. Am J Epidemiol. 2013;178(2): 296-308.
18. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 suppl): 273S-309S.
19. Chatterjee N, Sinha S, Diver WR, et al. Analysis of cohort studies with multivariate and partially observed disease classification data. Biometrika. 2010;97(3): 683-698.
20. Subar AF, Ziegler RG, Thompson FE, et al. Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. Am J Epidemiol. 2001;153(4): 404-409.
21. Sue LY, Schairer C, Ma X, et al. Energy intake and risk of postmenopausal breast cancer: an expanded analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Cancer Epidemiol Biomarkers Prev. 2009; 18(11):2842-2450.
22. Dowsett M, Cuzick J, Ingle J, et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol. 2010;28(3): 509-518.
23. Hefti MM, Hu R, Knoblauch NW, et al. Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. Breast Cancer Res. 2013; 15(4):R68.
24. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomized trials. Lancet. 2011;378(9793): 771-784.
25. Yang XR, Chang-Claude J, Goode EL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250-263.
26. Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9(1):R6.
27. Thakkar JP, Mehta DG. A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative. Oncologist. 2011;16(3):276-285.
28. Cui X, Schiff R, Arpino G, et al. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol. 2005;23(30):7721-7735.